Emerging Biopharma

Winding 3D road with dollar bills
Biotech

Frazier Life Sciences raises $1.3B for early-stage biotech fund

Frazier Life Sciences gathered an impressive $1.3 billion in capital commitments for its 12th venture fund aimed at private early-stage biotechs.
James Waldron Jul 31, 2025 7:54am
christmas cash gift money present holiday

BMS hands 5 autoimmune drugs to Bain-backed spinout

Jul 29, 2025 5:08am
spray painting

BMS-backed Dispatch unveils with $216M, Carl June as cofounder

Jul 23, 2025 6:30am
obesity drugs

MindRank reports 10% weight loss on oral GLP-1 drug in phase 2b

Jun 24, 2025 10:06am
china chinese Asia

Corxel, Sciwind post data as China's obesity push gathers pace

Jun 23, 2025 9:20am
red and purple piggy banks

Syncona cites 'challenging' market for switching investment plan

Jun 20, 2025 6:00am
More News

US biotechs must adapt as global competition rises: Antares CEO

Jun 17, 2025 8:15am

Astellas offers lab space to help Japanese biotechs 'go global'

Jun 13, 2025 4:41am

Novo Nordisk inks $812M Deep Apple deal to pursue obesity target

Jun 11, 2025 7:00am

Juri inks $210M T-cell engager deal with China biotech

May 27, 2025 6:00am